Published on Journal of Alzheimer's Disease (https://www.j-alz.com)

Home > Sembragiline in Moderate Alzheimer’s Disease: Results of a Randomized, Double-blind, Placebo-controlled Phase II Trial (MAyflOwer RoAD)

Sembragiline in Moderate Alzheimer’s Disease: Results of a Randomized, Double-blind, Placebo-controlled Phase II Trial (MAyflOwer RoAD)

Manuscript Number: 

16-1309R1

Author(s): 
Mercè Boada, Edilio Borroni, Tracie Carey, Christian Czech, Paul Delmar, Rachelle S. Doody, Juergen Dukart, Paulo Fontoura, Irene Gerlach, Inma Gilaberte, Timo Grimmer, Marie Mannino, Nicoletta Milani Muelhardt, Emma Moran, Stephane Nave, Tania Nikolcheva, Susanne Ostrowitzki, Meike Pauly-Evers, Benedicte Ricci, Luca Santarelli, Juha-Matti Savola
Source URL: https://www.j-alz.com/manuscript-disclosures/16-1309r1